Chengwu Zeng

Dr Zeng is a Professor of Hematology at the Key Laboratory for Regenerative Medicine of Ministry of Education and Institute of Hematology, Jinan University. He leads a multi-disciplinary research group focused on abnormalities affecting hematopoietic development, leading to hematological malignancies. More recently, his work has focused on the identification of novel targets, biomarkers, and potential drug targets for the treatment of leukemia. In particular, his main focus is to investigate the roles of several candidate genes including PML-RARA, miR-125b, NEAT1, CASP1, and TAL1 in leukemogenesis. Dr. Zeng has published over 20 papers and book chapters covering blood cancer biomarkers, lncRNAs, and microRNAs. These papers have received > 1,000 citations.